Oxidized proportion of muscle coenzyme Q10 increases with age in healthy children

Petra Niklowitz1, Jürgen Scherer1, Frank Döring2

  • 1Children's Hospital Datteln, Witten-Herdecke University, Datteln, Germany.

Pediatric Research
|June 25, 2015
PubMed

Insights

Plasma Coenzyme Q10 (CoQ10) levels do not reflect muscle CoQ10 status in children. Muscle CoQ10 shows an age-related shift towards oxidation, establishing new reference values for diagnosing deficiency.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Nutritional Science

Background:

  • Coenzyme Q10 (CoQ10) is vital for mitochondrial energy production and acts as an antioxidant.
  • CoQ10 deficiency can impair ATP synthesis and increase oxidative stress.
  • Plasma CoQ10 levels may not accurately indicate deficiency, especially in children.

Purpose of the Study:

  • To investigate the relationship between plasma and muscle CoQ10 concentration and redox status in healthy children.
  • To establish reference values for muscle CoQ10 in pediatric populations.
  • To explore age-related changes in CoQ10 status during childhood.

Main Methods:

  • High-performance liquid chromatography (HPLC) with electrochemical detection was used.
  • CoQ10 concentration and redox status were analyzed in plasma and muscle tissue.
  • 140 healthy children aged 0.8-15.3 years were included.

Main Results:

  • No correlation was found between plasma and muscle CoQ10 concentration or redox status.
  • Muscle CoQ10 exhibited a significant age-related increase in oxidation.
  • Reference values for muscle CoQ10 concentration and redox status were established for children.

Conclusions:

  • Plasma CoQ10 is not a reliable biomarker for muscle CoQ10 status in children.
  • The observed age-related redox shift in muscle indicates evolving antioxidant defenses.
  • Established reference values are crucial for diagnosing pediatric CoQ10 deficiency.
Abstract

Related Concept Videos

Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.8K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.3K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
338
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346